Clinical trial
An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension
NCT00151814 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- February 29, 2008
- Enrollment
- 24 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.